Avantect Design System
Purple carries risk, teal carries action, lime carries the data. Everything on this site is built from the system's own tokens and components.
Brand in one screen
The hero treatment as it appears in product.
When risk is elevated, clarity matters.
Avantect® is a blood-based test designed to detect signals of cancer at its earliest stages, supporting confident next-step decisions in elevated-risk care.
The clinical case
Stat rails and ring figures carry the survival argument.
Distant pancreatic cancer
Localised pancreatic cancer
Purple Flags
Risk-factor cards with the system's three illustrated icons.
Family History
A first-degree relative diagnosed with pancreatic cancer.
Relative Risk: 4x – 9x8,9
Genetic Predisposition
Pathogenic variants such as BRCA1/2, ATM, or Lynch syndrome.
Relative Risk: 5x – 132x10
New-Onset Diabetes
Diabetes first diagnosed after age 50.
Relative Risk: 6x – 8x11
Ordering journey
Three steps on a dashed purple rail.
Photography and product
Circle-cropped portraits and product shots on a quiet canvas.


Voice in practice
Hedged, cited, plain-spoken.
How to write it
Designed to inform, never to diagnose
Results read signal detected or signal not detected† — never positive or negative.
- Hedge words are required: signals, may, designed to.
- Avantect® on first mention, plain Avantect after.
- Cite every clinical figure inline.
- No emoji, ever.
Purple is a signal, not a button
Elevated risk deserves a next step
Purple backs risk content. Teal remains the only action colour on the surface, so the way forward is always unambiguous.
